E-Selectin Nasal Spray to Prevent Stroke Recurrence

Terminated

Phase 2 Results N/A

Summary of Purpose

This study will test the safety and effectiveness of a protein called E-selectin, given as a nasal spray, in preventing the formation of blood clots that can cause stroke. In animal studies, animals that received E-selectin in the nose on a regular schedule had almost no strokes compared with those that did not receive it. Patients over age 45 who have had a stroke or transient ischemic attack (TIA) within 1 to...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 May 2010.

1 Mar 2001 9 Mar 2001 Unavailable 1 Feb 2004 1 May 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study

Contacts

  • Patient Recruitment and Public Liaison Office Building 61 10 Cloister Court Bethesda, Maryland 20892-4754

    prpl@mail.cc.nih.gov